###begin article-title 0
###xml 52 56 <span type="species:ncbi:10090">Mice</span>
Interferon-lambda Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses
###end article-title 0
###begin p 1
Conceived and designed the experiments: GK PS. Performed the experiments: MM PS. Analyzed the data: MM GK PS. Contributed reagents/materials/analysis tools: LD JCR SRP KK. Wrote the paper: PS.
###end p 1
###begin p 2
###xml 422 425 410 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 416 425 404 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 721 724 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 994 997 972 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 988 997 966 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 1140 1143 1113 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 1134 1143 1107 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 1653 1656 1609 1612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 1647 1656 1603 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 614 631 <span type="species:ncbi:11320">influenza A virus</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 950 955 <span type="species:ncbi:10090">mouse</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
###xml 1144 1148 <span type="species:ncbi:10090">mice</span>
###xml 1208 1212 <span type="species:ncbi:10090">Mice</span>
###xml 1323 1327 <span type="species:ncbi:10090">mice</span>
###xml 1338 1342 <span type="species:ncbi:10090">mice</span>
###xml 1582 1586 <span type="species:ncbi:10090">mice</span>
###xml 1657 1661 <span type="species:ncbi:10090">mice</span>
Virus-infected cells secrete a broad range of interferon (IFN) subtypes which in turn trigger the synthesis of antiviral factors that confer host resistance. IFN-alpha, IFN-beta and other type I IFNs signal through a common universally expressed cell surface receptor, whereas IFN-lambda uses a distinct receptor complex for signaling that is not present on all cell types. Since type I IFN receptor-deficient mice (IFNAR10/0) exhibit greatly increased susceptibility to various viral diseases, it remained unclear to which degree IFN-lambda might contribute to innate immunity. To address this issue we performed influenza A virus infections of mice which carry functional alleles of the influenza virus resistance gene Mx1 and which, therefore, develop a more complete innate immune response to influenza viruses than standard laboratory mice. We demonstrate that intranasal administration of IFN-lambda readily induced the antiviral factor Mx1 in mouse lungs and efficiently protected IFNAR10/0 mice from lethal influenza virus infection. By contrast, intraperitoneal application of IFN-lambda failed to induce Mx1 in the liver of IFNAR10/0 mice and did not protect against hepatotropic virus infections. Mice lacking functional IFN-lambda receptors were only slightly more susceptible to influenza virus than wild-type mice. However, mice lacking functional receptors for both IFN-alpha/beta and IFN-lambda were hypersensitive and even failed to restrict usually non-pathogenic influenza virus mutants lacking the IFN-antagonistic factor NS1. Interestingly, the double-knockout mice were not more susceptible against hepatotropic viruses than IFNAR10/0 mice. From these results we conclude that IFN-lambda contributes to inborn resistance against viral pathogens infecting the lung but not the liver.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 125 130 <span type="species:ncbi:10090">mouse</span>
###xml 236 240 <span type="species:ncbi:10090">Mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">Mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
The contribution of IFN-lambda to innate immunity against virus-induced diseases has remained unclear to date as appropriate mouse models were not available. We now present evidence that IFN-lambda is involved in the antiviral defense. Mice lacking functional IFN-lambda receptors were only slightly more susceptible to influenza virus than wild-type mice, but intranasal administration of IFN-lambda efficiently protected IFN-alpha/beta receptor-deficient mice from lethal influenza virus infection and induced the antiviral factor Mx1 in lungs. Mice lacking functional receptors for both IFN-alpha/beta and IFN-lambda were hypersensitive and failed to restrict even usually non-pathogenic influenza virus mutants lacking the IFN-antagonistic factor NS1. By contrast, intraperitoneal application of IFN-lambda failed to induce Mx1 in the liver of mice and did not protect against hepatotropic viruses. Furthermore, double-knockout mice were not more susceptible against hepatotropic viruses than IFN-alpha/beta receptor-deficient mice, indicating that IFN-lambda contributes to resistance against viral pathogens infecting the lung but not the liver.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Yoneyama1">[1]</xref>
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Coccia1">[4]</xref>
###xml 292 295 292 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Pestka1">[5]</xref>
###xml 527 530 503 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-vanPesch1">[6]</xref>
###xml 754 757 706 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Kotenko1">[7]</xref>
###xml 758 761 710 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Sheppard1">[8]</xref>
###xml 993 996 940 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Dumoutier1">[9]</xref>
###xml 997 1001 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Zhou1">[10]</xref>
###xml 1150 1154 1093 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Brand1">[11]</xref>
###xml 1155 1159 1098 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Lasfar1">[12]</xref>
###xml 1413 1420 1346 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1539 1543 1467 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Sommereyns1">[13]</xref>
###xml 348 353 <span type="species:ncbi:10090">mouse</span>
###xml 594 599 <span type="species:ncbi:10090">mouse</span>
###xml 1533 1538 <span type="species:ncbi:10090">mouse</span>
Viral infection of vertebrate cells triggers innate immune responses, which result in rapid synthesis of IFN and other pro-inflammatory cytokines [1]-[4]. Virus-induced IFN represents a complex mixture of IFN subtypes which act on target cells by engaging two distinct cell surface receptors [5]. All members of the type I IFN family which, in the mouse, includes 14 different IFN-alpha subtypes, IFN-beta, IFN-kappa, IFN-epsilon and limitin, use the same heterodimeric IFN-alpha/beta receptor complex (IFNAR1/2) for signaling [6]. By contrast, signaling by type III IFN family members (in the mouse IFN-lambda2 and IFN-lambda3) occurs through the heterodimeric interleukin-28 receptor alpha/interleukin-10 receptor beta (IL-28Ralpha/IL-10Rbeta) complex [7],[8]. Although activating distinct receptor systems, IFN-lambda and type I IFNs trigger strikingly similar responses in target cells which mostly result from phosphorylation-induced activation of transcription factors STAT-1 and STAT-2 [9],[10]. The IFNAR1/2 complex is present on most if not all nucleated cells, whereas expression of the IL-28Ralpha subunit seems to be cell type-restricted [11],[12]. Consequently, antiviral protection by type I IFN is observed in most cell types, whereas antiviral protection mediated by IFN-lambda is restricted to cells that express functional IL-28R complexes. The spectrum of cell types that respond to IFN-lambda in vivo is poorly defined. Recent experiments suggested that epithelial cells are the main targets of IFN-lambda in the mouse [13].
###end p 6
###begin p 7
###xml 176 179 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 166 179 156 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 210 214 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Ank1">[14]</xref>
###xml 284 287 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 278 287 264 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 358 362 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Muller1">[15]</xref>
###xml 374 377 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 364 377 350 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 479 483 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Ank1">[14]</xref>
###xml 546 549 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 536 549 518 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 723 727 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Ank1">[14]</xref>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 695 722 <span type="species:ncbi:10310">herpes simplex virus type 2</span>
Information on the contribution of IFN-lambda to virus resistance at the level of the whole organism is very limited as mice lacking functional IFN-lambda receptors (IL28Ralpha0/0) were generated only recently [14]. Unlike knockout mice lacking functional type I IFN receptors (IFNAR10/0) that are highly susceptible to a broad spectrum of different viruses [15], IL28Ralpha0/0 and wild-type mice did not differ significantly in resistance to a large panel of pathogenic viruses [14]. The only observed difference between wild-type and IL28Ralpha0/0 mice was that treatment of knockout mice with toll-like receptor (TLR) 3 and TLR9 agonists failed to induce resistance to vaginal infection with herpes simplex virus type 2 [14].
###end p 7
###begin p 8
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1<sup>+/+</sup></italic>
###xml 137 140 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 134 140 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1<sup>+/+</sup></italic>
###xml 280 283 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 332 336 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Staeheli1">[16]</xref>
###xml 358 361 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 355 361 350 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1<sup>+/+</sup></italic>
###xml 400 403 395 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 564 568 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Tumpey1">[17]</xref>
###xml 569 573 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Haller1">[18]</xref>
###xml 582 585 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 579 585 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1<sup>+/+</sup></italic>
###xml 795 799 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Koerner1">[19]</xref>
###xml 938 942 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Tumpey1">[17]</xref>
###xml 1241 1244 1219 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 1277 1280 1255 1258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 1271 1280 1249 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 115 132 <span type="species:ncbi:11320">influenza A virus</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 586 591 <span type="species:ncbi:10090">mouse</span>
###xml 909 914 <span type="species:ncbi:9606">human</span>
###xml 1281 1285 <span type="species:ncbi:10090">mice</span>
Here we used Mx1+/+ mice to investigate the relative contributions of IFN-lambda and type I IFN in immunity toward influenza A virus. Mx1+/+ mice differ from standard mouse strains in being fully IFN-competent. They carry functional alleles of the influenza virus resistance gene Mx1, which is defective in standard laboratory mice [16]. Consequently, in Mx1+/+ mice, virus-induced IFN activates the Mx1 gene in addition to other antiviral genes, leading to a more complete innate immune response and more robust resistance to influenza and influenza-like viruses [17],[18]. The Mx1+/+ mouse model system has the power to reveal even subtle defects in antiviral immunity against orthomyxoviruses. It has recently been used to uncover the beneficial effect of IFN-beta in influenza virus defense [19]. It was further used to demonstrate that IFN-alpha might be used to prevent disease induced by highly lethal human H5N1 influenza viruses [17]. Using this experimental system we now demonstrate that IFN-lambda contributes to innate immunity against influenza virus but not against two different hepatotropic viruses. These differences in virus susceptibility correlated with the differing ability of virus-induced IFN-lambda to activate the Mx1 gene in lung and liver of IFNAR10/0 mice.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 64 67 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 58 67 53 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
IFN-lambda is induced in virus-infected lung and liver of IFNAR10/0 mice
###end title 10
###begin p 11
###xml 129 133 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Marie1">[20]</xref>
###xml 225 228 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 219 228 212 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 330 338 323 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g001">Figure 1</xref>
###xml 608 612 581 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-GarciaSastre1">[21]</xref>
###xml 613 617 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Kochs1">[22]</xref>
###xml 743 746 704 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 737 746 698 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 868 872 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Hagmaier1">[23]</xref>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 497 514 <span type="species:ncbi:11320">influenza A virus</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
Since virus-induced activation of IFN genes requires positive feedback through the IFN-alpha/beta receptor in certain cell types [20], we first determined whether the major IFN subtypes are induced in lung and liver of IFNAR10/0 mice after infection with viruses that strongly activate the innate immune system. As can be seen in Figure 1, we observed strong transcriptional activation of genes for the IFN-alpha family, IFN-beta and IFN-lambda2 in the lung of mice infected intranasally with the influenza A virus mutants SC35M-DeltaNS1 and PR8-DeltaNS1 that are known to induce large amounts of type I IFN [21],[22]. Similarly, strong transcriptional activation of IFN-alpha, IFN-beta and IFN-lambda genes was observed in the liver of IFNAR10/0 mice infected with a mutant of hepatotropic Thogotovirus (THOV) that lacks the IFN-antagonistic factor ML (THOV-DeltaML) [23].
###end p 11
###begin title 12
###xml 73 76 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 67 76 62 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Induction of IFN-lambda2 genes in virus-infected lung and liver of IFNAR10/0 mice.
###end title 12
###begin p 13
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 69 86 <span type="species:ncbi:11320">influenza A virus</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 414 419 <span type="species:ncbi:10090">mouse</span>
Animals were either infected by the intranasal route with 106 pfu of influenza A virus strain SC35M-DeltaNS1 or PR8-DeltaNS1, or else by the intraperitoneal route with 10 pfu of hepatotropic THOV-DeltaML. Animals treated with plain buffer served as negative controls. At 17 hours post infection, the influenza virus-infected mice were killed and the lungs were removed for analysis. The liver of the THOV-infected mouse was harvested when the animal was severely diseased at 72 hours post infection. RNA samples from the organs were reverse transcribed and analyzed by PCR for transcripts of the indicated genes.
###end p 13
###begin title 14
###xml 36 39 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 30 39 25 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 79 96 <span type="species:ncbi:11320">influenza A virus</span>
Exogenous IFN-lambda protects IFNAR10/0 mice against intranasal challenge with influenza A virus but not against intraperitoneal challenge with Thogotovirus
###end title 14
###begin p 15
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 23 32 23 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 239 242 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 233 242 228 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 496 498 469 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 553 557 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Kochs1">[22]</xref>
###xml 777 784 740 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g002">Fig. 2A</xref>
###xml 808 811 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 802 811 765 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 836 839 799 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 1051 1054 1004 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1048 1054 1001 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1<sup>+/+</sup></italic>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 503 508 <span type="species:ncbi:10090">mouse</span>
###xml 522 539 <span type="species:ncbi:11320">influenza A virus</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 1055 1059 <span type="species:ncbi:10090">mice</span>
In a first experiment, IFNAR10/0 mice were treated with exogenous IFN-lambda by the intranasal route to determine whether this cytokine might contribute to protection from pneumonia induced by pathogenic influenza viruses. Groups of IFNAR10/0 mice were treated with 7,500 units of either recombinant IFN-lambda2 or IFN-lambda3. Control animals received corresponding volumes of a mock preparation. Ten hours later, the animals were infected with 100 plaque-forming units (pfu) (approximately20 LD50) of mouse-adapted H7N7 influenza A virus strain SC35M [22]. The control animals quickly lost weight and had to be killed between days 7 and 9 post infection due to clinical signs of pneumonia, whereas all animals treated with either IFN-lambda2 or IFN-lambda3 remained healthy (Fig. 2A). Since standard IFNAR10/0 mice lacking functional Mx1 alleles developed severe disease under identical experimental conditions in spite of treatment with IFN-lambda3 (data not shown), we concluded that the protective effect of IFN-lambda that we observed in our Mx1+/+ mice was mainly mediated by the IFN-induced resistance factor Mx1.
###end p 15
###begin title 16
###xml 36 39 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 30 39 25 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 79 96 <span type="species:ncbi:11320">influenza A virus</span>
Exogenous IFN-lambda protects IFNAR10/0 mice against intranasal challenge with influenza A virus but not against intraperitoneal challenge with THOV.
###end title 16
###begin p 17
###xml 180 182 158 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 383 385 344 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 187 204 <span type="species:ncbi:11320">influenza A virus</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
(A) Survival of mice intranasally treated for 10 hours with a mock preparation or 7,500 units of either IFN-lambda2 or IFN-lambda3 before challenge with 100 pfu (approximately20 LD50) of influenza A virus strain SC35M. (B) Survival of mice intraperitoneally treated for 10 hours with a mock preparation or 15,000 units of IFN-lambda3 before infection with 100 pfu (approximately20 LD50) of THOV.
###end p 17
###begin p 18
###xml 103 106 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 97 106 92 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 221 223 204 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 391 398 369 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g002">Fig. 2B</xref>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
In a second experiment, 15,000 units of IFN-lambda3 were applied by the intraperitoneal route to IFNAR10/0 mice carrying functional Mx1 alleles. Ten hours later the animals were challenged with 100 pfu (approximately20 LD50) of THOV. Animals treated with IFN-lambda3 as well as control animals treated with a mock preparation developed severe disease between 48 and 96 hours post infection (Fig. 2B). Thus, IFN-lambda exhibited effective antiviral activity in the lung, but seemed to be inactive in the liver.
###end p 18
###begin title 19
###xml 21 24 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 76 79 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 70 79 65 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
IFN-lambda activates Mx1 gene expression in the lung but not liver of IFNAR10/0 mice
###end title 19
###begin p 20
###xml 155 159 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Ank2">[24]</xref>
###xml 304 307 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 395 398 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 389 398 379 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 685 692 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g003">Fig. 3A</xref>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
Like type I IFN, IFN-lambda exhibits antiviral activity by binding to a specific cell receptor complex that can activate latent STAT transcription factors [24]. After activation, the STAT proteins move to the nucleus where they activate transcription of a large number of IFN-responsive genes, including Mx1. To determine whether exogenous IFN-lambda activates IFN-responsive genes in our IFNAR10/0 mice, we harvested lung and liver at 20 hours post onset of treatment with IFN-lambda3 and analyzed the tissue homogenates for Mx1 protein by western blotting. Easily detectable levels of Mx1 were present in lungs of mice that were treated intranasally with 3,500 units of IFN-lambda3 (Fig. 3A). The lungs of mock-treated mice did not contain detectable levels of Mx1.
###end p 20
###begin title 21
###xml 21 24 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 72 75 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
IFN-lambda activates Mx1 gene expression in lung but not liver of IFNAR10/0 mice.
###end title 21
###begin p 22
###xml 277 280 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 271 280 266 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
###xml 603 608 <span type="species:ncbi:9606">human</span>
(A) Western blot analysis of Mx1 protein levels in lungs of mice at 20 hours post intranasal application of 3,500 units of IFN-lambda3. Animals treated with a mock preparation served as control. Two animals of each group are shown. (B) Mx1 protein levels in the liver of IFNAR10/0 mice at 20 hours post intraperitoneal application of 15,000 units of IFN-lambda3 or terminally ill at 72 hours post infection with hepatotropic THOV-DeltaML or RVFV clone 13. Two animals for each group are shown. Liver extract from a wild-type mouse killed at 20 hours post intraperitoneal treatment with 100,000 units of human IFN-alphaB/D served as positive control.
###end p 22
###begin p 23
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 50 59 50 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 136 143 131 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g003">Fig. 3B</xref>
###xml 302 309 293 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g003">Fig. 3B</xref>
###xml 566 569 547 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 560 569 541 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 650 656 622 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g001">Fig. 1</xref>
###xml 758 765 730 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g003">Fig. 3B</xref>
###xml 849 852 821 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 843 852 815 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 906 913 878 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g003">Fig. 3B</xref>
###xml 977 981 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Bouloy1">[25]</xref>
###xml 1120 1123 1082 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 1114 1123 1076 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 853 857 <span type="species:ncbi:10090">mice</span>
###xml 872 895 <span type="species:ncbi:11588">Rift Valley fever virus</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
Mx1 protein could not be detected in the liver of IFNAR10/0 mice treated with 15,000 units of IFN-lambda3 by the intraperitoneal route (Fig. 3B). If, as a control, a cross-reactive variant of human IFN-alpha was injected by the same route into wild-type mice, Mx1 was prominently induced in the liver (Fig. 3B). To distinguish between the possibility that liver cells lack functional receptors for IFN-lambda and the possibility that the recombinant IFN-lambda failed to reach the liver under our experimental conditions, we analyzed the Mx1 protein levels in IFNAR10/0 mice infected with THOV-DeltaML which strongly induces IFN-lambda in the liver (Fig. 1). The liver of mice with severe THOV-induced disease contained no detectable amounts of Mx1 protein (Fig. 3B). Similarly, no Mx1 protein could be detected in the liver of terminally ill IFNAR10/0 mice infected with Rift Valley fever virus clone 13 (Fig. 3B), another hepatotropic virus with strong IFN-inducing activity [25]. Thus, differential IFN-lambda receptor expression in lung and liver seemed to explain why exogenously applied IFN-lambda protected IFNAR10/0 mice from virus-induced disease of the lung but not the liver.
###end p 23
###begin title 24
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Slightly reduced resistance to influenza virus of mice lacking functional IFN-lambda receptors
###end title 24
###begin p 25
###xml 134 137 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 124 137 119 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 270 273 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 260 273 251 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 304 305 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 365 368 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 355 368 342 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 423 430 406 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g004">Fig. 4A</xref>
###xml 522 525 501 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 512 525 495 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 626 633 605 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g004">Fig. 4B</xref>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
To directly assess the contribution of IFN-lambda to the protection from influenza virus-induced lung disease, we generated IL28Ralpha0/0 mice carrying functional Mx1 alleles by crossbreeding of appropriate mouse strains and compared the fate of wild-type and IL28Ralpha0/0 mice after challenge with 5x104 plaque-forming units (pfu) of SC35M. Survival of IL28Ralpha0/0 mice was slightly reduced compared to wild-type mice (Fig. 4A), but the difference was not statistically significant. Viral titers in lungs of IL28Ralpha0/0 mice were slightly but significantly higher at 72 h post infection than in lungs of wild-type mice (Fig. 4B).
###end p 25
###begin title 26
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 85 102 <span type="species:ncbi:11320">influenza A virus</span>
Mice lacking functional receptors for IFN-lambda show slightly reduced resistance to influenza A virus.
###end title 26
###begin p 27
###xml 24 27 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 14 27 14 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 80 81 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Wild-type and IL28Ralpha0/0 mice were infected by the intranasal route with 5x104 pfu of SC35M. (A) Survival and (B) virus titers in lungs at 72 hours post infection were recorded. Combined data of several independent experiments are shown. (**: p<0.01).
###end p 27
###begin title 28
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 82 91 82 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Strongly reduced resistance to influenza virus but not to hepatotropic viruses of IFNAR10/0 mice lacking functional receptors for IFN-lambda
###end title 28
###begin p 29
###xml 110 113 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 107 113 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1<sup>+/+</sup></italic>
###xml 194 197 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 207 210 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 188 210 176 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup>IL28R&#945;<sup>0/0</sup></italic>
###xml 321 324 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 315 324 292 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 342 345 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 422 426 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Koerner1">[19]</xref>
###xml 465 466 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 521 524 494 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 515 524 488 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 531 538 504 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g005">Fig. 5A</xref>
###xml 580 583 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 570 583 543 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 635 636 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 707 710 672 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 720 723 681 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 701 723 666 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup>IL28R&#945;<sup>0/0</sup></italic>
###xml 761 762 722 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 860 867 817 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g005">Fig. 5A</xref>
###xml 965 967 922 924 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 995 998 948 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 1008 1011 957 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 989 1011 942 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup>IL28R&#945;<sup>0/0</sup></italic>
###xml 1053 1054 1002 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1060 1067 1009 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g005">Fig. 5A</xref>
###xml 1233 1234 1178 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1259 1262 1204 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 1272 1275 1213 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 1253 1275 1198 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup>IL28R&#945;<sup>0/0</sup></italic>
###xml 1374 1377 1315 1318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 1368 1377 1309 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 1417 1424 1358 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g005">Fig. 5B</xref>
###xml 1571 1578 1508 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g005">Fig. 5C</xref>
###xml 1599 1606 1536 1543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g005">Fig. 5D</xref>
###xml 1713 1716 1645 1648 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 1707 1716 1639 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1105 1109 <span type="species:ncbi:10090">mice</span>
###xml 1167 1172 <span type="species:ncbi:9606">human</span>
###xml 1173 1190 <span type="species:ncbi:11320">influenza A virus</span>
###xml 1292 1296 <span type="species:ncbi:10090">mice</span>
###xml 1394 1398 <span type="species:ncbi:10090">mice</span>
###xml 1472 1476 <span type="species:ncbi:10090">mice</span>
###xml 1584 1588 <span type="species:ncbi:11588?0.9375">RVFV</span>
###xml 1717 1721 <span type="species:ncbi:10090">mice</span>
To determine the relative contributions of IFN-alpha/beta and IFN-lambda in antiviral defense we generated Mx1+/+ mice that lack functional receptors for both of these two classes of IFN (IFNAR10/0IL28Ralpha0/0) and compared them to mice that lack receptors for IFN-alpha/beta only. We previously demonstrated that IFNAR10/0 mice with intact Mx1 alleles are highly susceptible to challenge infections with wild-type SC35M [19]. However, intranasal infection with 105 pfu of SC35M-DeltaNS1 did not induce disease in IFNAR10/0 mice (Fig. 5A). Similarly, all wild-type and IL28Ralpha0/0 mice remained healthy when challenged with up to 106 pfu of SC35M-DeltaNS1 (data not shown). In marked contrast, all IFNAR10/0IL28Ralpha0/0 double-knockout mice infected with 105 pfu of SC35M-DeltaNS1 developed severe disease and had to be killed around day 5 post infection (Fig. 5A). Additional experiments in which we used lower doses of challenge virus demonstrated that the LD50 of SC35M-DeltaNS1 in IFNAR10/0IL28Ralpha0/0 double-knockout mice was approximately 103 pfu (Fig. 5A). A similar picture emerged when the mice were challenged with a NS1-deficient variant of the H1N1 human influenza A virus strain PR8 (PR8-DeltaNS1). At a dose of 106 pfu, all infected IFNAR10/0IL28Ralpha0/0 double-knockout mice developed severe pneumonia within 4-6 days post infection, whereas all IFNAR10/0 single-knockout mice remained healthy (Fig. 5B). Importantly, our single- and double-knockout mice did not differ in susceptibility to infection with the two hepatotropic viruses THOV-DeltaML (Fig. 5C) and RVFV clone 13 (Fig. 5D), strongly supporting the above-formulated conclusion that IFN-lambda is not active in the liver of IFNAR10/0 mice.
###end p 29
###begin title 30
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking functional receptors for both IFN-alpha/beta and IFN-lambda exhibit enhanced susceptibility toward highly attenuated influenza A viruses but not toward two different attenuated hepatotropic viruses.
###end title 30
###begin p 31
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 12 21 12 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 56 59 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 37 59 37 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup>IL28R&#945;<sup>0/0</sup></italic>
###xml 198 199 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:11588?0.9375">RVFV</span>
Survival of IFNAR10/0 (diamonds) and IFNAR10/0IL28Ralpha0/0 double knockout mice (circles) after (A) intranasal infection with the indicated doses of SC35M-DeltaNS1, (B) intranasal infection with 106 pfu of PR8-DeltaNS1, (C) intraperitoneal infection with the indicated doses of THOV-DeltaML, and (D) intraperitoneal infection with the indicated doses of RVFV clone 13. Groups consisted of four to nine animals.
###end p 31
###begin title 32
###xml 28 32 <span type="species:ncbi:10090">mice</span>
High virus load in lungs of mice correlates with low Mx1 protein levels
###end title 32
###begin p 33
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 300 303 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 290 303 286 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 333 340 325 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g006">Fig. 6A</xref>
###xml 413 416 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 407 416 395 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 483 486 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 496 499 480 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 477 499 465 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup>IL28R&#945;<sup>0/0</sup></italic>
###xml 522 529 506 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g006">Fig. 6A</xref>
###xml 624 627 600 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 614 627 594 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 688 695 664 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g006">Fig. 6B</xref>
###xml 722 725 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 716 725 692 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 863 866 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 857 871 833 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup>IL28R</italic>
###xml 876 879 848 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 876 879 848 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>0/0</sup></italic>
###xml 902 909 874 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g006">Fig. 6B</xref>
###xml 969 972 937 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
###xml 1001 1005 <span type="species:ncbi:10090">mice</span>
Virus replication in lungs of wild-type and mutant mice was assessed at 48 hours post infection with 105 pfu of SC35M-DeltaNS1. Virus titers in lungs of wild-type mice were below the detection limit in four of five animals, and they were only slightly above the detection limit in lungs of IL28Ralpha0/0 mice at 48 h post infection (Fig. 6A). Remarkably, SC35M-DeltaNS1 did not grow much better in lungs of IFNAR10/0 mice, whereas it replicated to very high titers in lungs of IFNAR10/0IL28Ralpha0/0 double-knockout mice (Fig. 6A). At 20 hours post infection with SC35M-DeltaNS1 the Mx1 protein levels in lungs of IL28Ralpha0/0 mice were about 2-fold lower than in the wild-type animals (Fig. 6B). Lungs of infected IFNAR10/0 mice contained about 10-fold lower levels of Mx1 protein than wild-type mice, whereas Mx1 levels were below the detection limit in IFNAR10/0IL28Ralpha0/0 double-knockout mice (Fig. 6B). Thus, after infection with SC35M-DeltaNS1, the extent of Mx1 gene expression in lungs of mice with defective receptors for IFN-alpha/beta, IFN-lambda or both correlated inversely with virus titers.
###end p 33
###begin title 34
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Inverse correlation of Mx1 protein levels and viral load in lungs of mice lacking functional receptors for IFN-alpha/beta, IFN-lambda or both.
###end title 34
###begin p 35
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
Groups of mice were infected with 105 pfu of SC35M-DeltaNS1 and either killed at (A) 48 hours post infection to determine viral titers in the lung or at (B) 20 hours post infection to determine Mx1 protein levels by western blotting. Two animals of each group are shown. Actin-normalized Mx1 signal intensities are indicated. The calculated value of the wild-type mice was set to 100%. (*: p<0.05), ***: p<0.001).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 98 101 86 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Dumoutier1">[9]</xref>
###xml 102 106 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Zhou1">[10]</xref>
###xml 345 349 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Ank1">[14]</xref>
###xml 560 564 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Ank1">[14]</xref>
###xml 712 716 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Muller1">[15]</xref>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 469 496 <span type="species:ncbi:10310">herpes simplex virus type 2</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
The intracellular signaling pathways activated by IFN-lambda and IFN-alpha/beta are quite similar [9],[10], suggesting that both IFN types are contributing to virus resistance. Surprisingly, however, mice lacking functional receptors for IFN-lambda did not differ from wild-type mice when challenged with a panel of different pathogenic viruses [14]. A mild deficiency of IFN-lambda-deficient mice became only apparent in an experimental setting in which resistance to herpes simplex virus type 2 was induced by treating the animals with TLR3 or TLR9 agonists [14]. This phenotype is in marked contrast to that of mice lacking functional receptors for IFN-alpha/beta which are highly susceptible to many viruses [15].
###end p 37
###begin p 38
###xml 282 286 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Domanski1">[26]</xref>
###xml 370 374 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Sommereyns1">[13]</xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
We reasoned that the different phenotypes of the knockout mice might be explained by the different expression patterns of the receptors for IFN-alpha/beta and IFN-lambda in the organism. Receptors for IFN-alpha/beta are rather uniformly expressed on most if not all nucleated cells [26], whereas receptors for IFN-lambda are preferentially expressed on epithelial cells [13]. If our reasoning was correct, one would predict that the protective effect of IFN-lambda should be restricted to organs with a high percentage of cells expressing the IFN-lambda receptor and that the protective effect of IFN-lambda in these organs might be most obvious when the IFN-alpha/beta system is defective. In this report we provide evidence that strongly supports this view.
###end p 38
###begin p 39
###xml 237 243 227 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g002">Fig. 2</xref>
###xml 662 668 633 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g003">Fig. 3</xref>
###xml 835 841 796 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g003">Fig. 3</xref>
###xml 939 945 895 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g001">Fig. 1</xref>
###xml 1256 1260 1198 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Sommereyns1">[13]</xref>
###xml 1490 1494 1427 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Robek1">[27]</xref>
###xml 1693 1700 1625 1632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1700 1704 1632 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Robek1">[27]</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 100 117 <span type="species:ncbi:11320">influenza A virus</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 964 969 <span type="species:ncbi:10090">mouse</span>
###xml 1251 1255 <span type="species:ncbi:10090">mice</span>
###xml 1384 1401 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 1419 1425 <span type="species:ncbi:10090">murine</span>
###xml 1581 1585 <span type="species:ncbi:10090">mice</span>
###xml 1663 1680 <span type="species:ncbi:10407">hepatitis B virus</span>
We observed that intranasal application of IFN-lambda protected the mice from lethal challenge with influenza A virus, whereas systemic application of IFN-lambda failed to mediate protection from disease induced by a hepatotropic virus (Fig. 2). It should be noted that the mice employed here lacked functional IFN-alpha/beta receptors, excluding the possibility that the protective effect in the lung was indirect and resulted from IFN-alpha/beta that might have been induced by undefined contaminating substances in our IFN-lambda preparations. Protection against influenza virus correlated with the presence of the IFN-induced Mx1 protein in the lung tissue (Fig. 3), suggesting that lung epithelial cells carry functional IFN-lambda receptors. By contrast, no Mx1 protein was found in liver tissue of mice treated with IFN-lambda (Fig. 3). The liver tissue also failed to respond to IFN-lambda synthesized in the virus-infected liver (Fig. 1), suggesting that mouse liver cells do not express functional receptors for IFN-lambda. This latter conclusion is in agreement with results from recent quantitative RT-PCR analyses which showed that the alpha chain of the IFN-lambda receptor (IL28R-alpha) is expressed only at very low levels in liver of mice [13]. However, our results appear to be in conflict with a previous report in which IFN-lambda was successfully used to inhibit hepatitis B virus replication in a murine hepatocyte cell line expressing the viral genome as a transgene [27]. However, these authors observed no induction of IFN-responsive genes in the liver of mice treated with large amounts of IFN-lambda, and they observed no inhibition of hepatitis B virus replication in vivo[27]. In this respect, hepatocyte cell lines may not mirror the normal behavior of hepatocytes in intact liver tissue.
###end p 39
###begin p 40
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Ank1">[14]</xref>
###xml 712 718 678 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g005">Fig. 5</xref>
###xml 923 927 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-GarciaSastre1">[21]</xref>
###xml 1079 1083 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-GarciaSastre1">[21]</xref>
###xml 1168 1172 1134 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Decker1">[28]</xref>
###xml 1386 1400 1345 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000151-g005">Figs 5A and 5B</xref>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1059 1063 <span type="species:ncbi:10090">mice</span>
###xml 1319 1323 <span type="species:ncbi:10090">mice</span>
###xml 1380 1384 <span type="species:ncbi:10090">mice</span>
###xml 1558 1562 <span type="species:ncbi:10090">mice</span>
###xml 1801 1805 <span type="species:ncbi:10090">mice</span>
Since the virus challenge studies in a former report [14] were carried out with IFN-lambda receptor knockout mice lacking the IFN-induced influenza virus resistance factor Mx1, it remained possible that the beneficial effect of IFN-lambda against influenza virus had previously been underestimated. Yet, our new experiments with Mx1-positive mice revealed that the lack of IFN-lambda system has indeed a much less drastic effect on virus resistance than the lack of the IFN-alpha/beta system. The protective role of IFN-lambda became only apparent in Mx1-positive mice that lack a functional IFN-alpha/beta system, and it was most prominent if influenza virus mutants with high IFN-inducing potential were used (Fig. 5). It is well known that highly pathogenic influenza viruses are not controlled well by the IFN system because the virus-encoded NS1 protein counteracts efficient activation of IFN genes in infected cells [21]. NS1-deficient influenza viruses which are very potent IFN inducers are highly attenuated in wild-type mice but remain virulent in mice lacking STAT-1 [21], a transcription factor centrally placed in the signaling pathways of all IFN types [28]. We found that mutants of the influenza virus strains SC35M and PR8 lacking NS1 were completely non-virulent in IFN-alpha/beta receptor-deficient mice and failed to replicate efficiently in the lung of such mice (Figs 5A and 5B), which should not be the case if IFN-alpha/beta was the only IFN subtype that confers resistance to influenza viruses. Our observation that double knockout mice lacking functional receptors for IFN-alpha/beta and IFN-lambda are highly susceptible to the NS1-deficient influenza virus mutants clearly demonstrates that IFN-lambda provides the residual protection in IFN-alpha/beta receptor-deficient mice.
###end p 40
###begin p 41
###xml 1024 1028 973 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Bartlett1">[29]</xref>
###xml 1290 1294 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Johnson1">[30]</xref>
###xml 1523 1527 1455 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Sommereyns1">[13]</xref>
###xml 320 337 <span type="species:ncbi:11320">influenza A virus</span>
###xml 977 991 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
###xml 1166 1170 <span type="species:ncbi:10090">mice</span>
###xml 1206 1239 <span type="species:ncbi:11250">human respiratory syncytial virus</span>
###xml 1285 1289 <span type="species:ncbi:10090">mice</span>
###xml 1366 1393 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 1790 1796 <span type="species:ncbi:9606">humans</span>
Some important conclusions can be drawn from our data regarding the role of different IFN types in antiviral immunity. First, the virus defense strategy of the lung is not exclusively based on the IFN-alpha/beta system. Our data clearly demonstrate that the IFN-lambda system also contributes to innate immunity against influenza A virus. The second important conclusion from our study is that the IFN-alpha/beta system is dominant over the IFN-lambda system. IFN-lambda thus appears to be part of a secondary defense system which can fill gaps left by the IFN-alpha/beta system. Future studies will help to distinguish between the possibility that IFN-lambda is predominantly active against influenza viruses and the possibility that IFN-lambda plays a broader role in the lung and improves innate immunity against other pathogenic viruses that infect the respiratory tract. Evidence in favor of the second possibility includes the observation that IFN-lambda also restricted vaccinia virus replication in the lung of mice [29]. We further noted with interest that, reminiscent to the situation with NS1-deficient influenza virus, IFN-alpha/beta receptor-deficient mice are able to restrict the growth of human respiratory syncytial virus in the lung far better than STAT-1-deficient mice [30]. This observation suggests that IFN-lambda might also help controlling respiratory syncytial virus. Since receptors for IFN-lambda are expressed on epithelial cells of many different organs including lung, stomach and intestine [13], it is conceivable that the physiological role of this cytokine is to protect the host from viral infections via mucosal membranes at many different body sites. An important issue to be addressed in the future is whether IFN-lambda might serve a similar role in humans.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 43
###begin p 44
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Horisberger1">[31]</xref>
###xml 99 102 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 126 135 126 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Koerner1">[19]</xref>
###xml 271 274 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 261 274 261 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;<sup>0/0</sup></italic>
###xml 276 280 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Ank1">[14]</xref>
###xml 306 309 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 321 324 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 331 334 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0/0</sup>
###xml 325 334 321 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1<sup>0/0</sup></italic>
###xml 371 374 367 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mx1</italic>
###xml 409 419 405 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;</italic>
###xml 429 439 421 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL28R&#945;</italic>
###xml 444 450 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1</italic>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
All animals used were of C57BL/6 genetic background. Congenic B6.A2G-Mx1 mice [31] carrying intact Mx1 alleles and B6.A2G-Mx1-IFNAR10/0 mice lacking functional type I IFN receptors [19] were bred locally. C57BL/6 mice lacking functional type III IFN receptors (IL28Ralpha0/0) [14] were crossed with B6.A2G-Mx1 and B6.A2G-Mx1-IFNAR10/0 mice to produce strains with intact Mx1 alleles and defective alleles for IL28Ralpha only, or IL28Ralpha and IFNAR1 in combination. Six- to eight-week-old animals were used for all infection experiments, which were performed in accordance with the guidelines of the local animal care committee. Animals were euthanized if severe symptoms developed or body weight loss approached 30% of the initial value.
###end p 44
###begin title 45
Viruses
###end title 45
###begin p 46
###xml 112 116 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Kochs1">[22]</xref>
###xml 134 138 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-GarciaSastre1">[21]</xref>
###xml 288 292 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Hagmaier1">[23]</xref>
###xml 412 416 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Bouloy1">[25]</xref>
###xml 18 35 <span type="species:ncbi:11320">influenza A virus</span>
###xml 334 357 <span type="species:ncbi:11588">Rift Valley fever virus</span>
###xml 359 363 <span type="species:ncbi:11588?0.9375">RVFV</span>
We used wild-type influenza A virus strains SC35M (H7N7) and A/PR/8/34 (H1N1) as well as mutants SC35M-DeltaNS1 [22] and PR8-DeltaNS1 [21] lacking the IFN-antagonistic factor NS1. We further used wild-type Thogotovirus (THOV) or mutant THOV-DeltaML lacking the IFN-antagonistic factor ML [23], and the attenuated "clone 13" strain of Rift Valley fever virus (RVFV) lacking functional IFN-antagonistic factor NSs [25]. All these viruses are classified as BSL2 pathogens in Germany.
###end p 46
###begin title 47
Virus infections
###end title 47
###begin p 48
###xml 298 302 <span type="species:ncbi:11588?0.9375">RVFV</span>
Animals were anesthetized by intraperitoneal injection of a mixture of ketamine (100 microg per gram body weight) and xylazine (5 microg per gram body weight) before intranasal infection with the indicated doses of the various influenza A viruses in 50 microl PBS containing 0.3% BSA. For THOV and RVFV infections, 100 microl-samples of diluted virus stocks were applied intraperitoneally without anaesthesia.
###end p 48
###begin title 49
Cytokines
###end title 49
###begin p 50
###xml 119 122 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Dumoutier1">[9]</xref>
###xml 218 222 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Chi1">[32]</xref>
###xml 316 320 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Tumpey1">[17]</xref>
###xml 321 325 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Horisberger2">[33]</xref>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 275 280 <span type="species:ncbi:10090">mouse</span>
IFN-lambda2 and IFN-lambda3 were produced by transient transfection of 293T cells with appropriate expression plasmids [9]. The biological activity of IFN-lambda2 and IFN-lambda3 was determined as previously described [32]. Hybrid human IFN-alphaB/D that is highly active on mouse cells was used as positive control [17],[33].
###end p 50
###begin title 51
###xml 17 21 <span type="species:ncbi:10090">mice</span>
IFN treatment of mice
###end title 51
###begin p 52
Samples containing the indicated amounts of IFN-lambda2 or IFN-lambda3 were either applied intranasally (50 microl) to anesthetized animals or injected intraperitoneally (200-300 microl) without anaesthesia.
###end p 52
###begin title 53
Titration of virus in lungs
###end title 53
###begin p 54
Lung homogenates were prepared by grinding the tissue using a mortar and sterile quartz sand. Homogenates were suspended in 1 ml of PBS, and tissue debris was removed by low speed centrifugation. Virus titers in supernatants were determined by performing plaque assays on MDCK II cells by serial 10-fold dilutions in PBS containing 0.3% BSA.
###end p 54
###begin title 55
RT-PCR
###end title 55
###begin p 56
###xml 492 497 <span type="species:ncbi:10090">mouse</span>
###xml 580 585 <span type="species:ncbi:10090">mouse</span>
###xml 672 677 <span type="species:ncbi:10090">mouse</span>
###xml 767 772 <span type="species:ncbi:10090">mouse</span>
Lung and liver were removed, and frozen immediately in liquid nitrogen. RNA was isolated from the organs using 1 ml of TriFast according to the protocol of the manufacturer (peQLab). The RNA was further purified by using RNeasy mini kit columns (Qiagen). One microg of each RNA preparation was reverse-transcribed using random-hexamer primers and reverse transcriptase. The reaction products were used to amplify the cDNAs by Taq polymerase for 30 cycles using the indicated primer pairs for mouse IFN-beta (accession no. NM_010510, primers from positions 21-42 and 145-124), the mouse IFN-alpha family (accession no. NM_010504, primers from positions 46-68 and 557-534), mouse IFN-lambda2 (accession no. NM_001024673, primers from positions 83-104 and 191-170), and mouse beta-actin (accession no. X03672, primers from positions 1374-1396 and 1585-1564). RT-PCR products were separated by agarose electrophoresis, stained with ethidium bromide and visualized under UV light.
###end p 56
###begin title 57
Western blot analysis
###end title 57
###begin p 58
###xml 707 711 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000151-Flohr1">[34]</xref>
###xml 675 680 <span type="species:ncbi:10090">mouse</span>
###xml 727 732 <span type="species:ncbi:10090">mouse</span>
###xml 765 776 <span type="species:ncbi:3704">Horseradish</span>
Lung homogenates were prepared by grinding the tissue using a mortar and sterile quartz sand. Homogenates were lysed in buffer containing 50 mM Hepes (pH 7.3), 125 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT, 100 units/ml of benzonase, and protease inhibitors as recommended by the manufacturer (Roche). Lysates were subjected to low speed centrifugation, and supernatants were diluted with concentrated gel loading buffer containing beta-mercaptoethanol. Proteins were separated by SDS-polyacrylamide gel electrophoresis (10% gel) and transferred onto polyvinyliden-fluoride membranes (Millipore). The blots were probed with monoclonal mouse antibody specific for Mx1 [34] and monoclonal mouse antibody against actin (Sigma). Horseradish peroxidase-labeled secondary antibodies and the chemoluminescence detection system (Pierce) were used to detect primary antibodies. Signal quantification was done with a ChemiDoc XRS equipment (BioRad).
###end p 58
###begin p 59
We thank Prof. Dr. J. Schulte Monting for help with the statistical analysis of our data, and Otto Haller and Friedemann Weber for helpful comments on the manuscript.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
Function of RIG-I-like receptors in antiviral innate immunity.
###end article-title 61
###begin article-title 62
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.
###end article-title 62
###begin article-title 63
Toll-like receptors and Type I interferons.
###end article-title 63
###begin article-title 64
###xml 117 122 <span type="species:ncbi:9606">human</span>
Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells.
###end article-title 64
###begin article-title 65
Interferons, interferon-like cytokines, and their receptors.
###end article-title 65
###begin article-title 66
###xml 24 30 <span type="species:ncbi:10090">murine</span>
Characterization of the murine alpha interferon gene family.
###end article-title 66
###begin article-title 67
IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.
###end article-title 67
###begin article-title 68
IL-28, IL-29 and their class II cytokine receptor IL-28R.
###end article-title 68
###begin article-title 69
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.
###end article-title 69
###begin article-title 70
Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases.
###end article-title 70
###begin article-title 71
###xml 100 106 <span type="species:ncbi:10090">murine</span>
###xml 107 110 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.
###end article-title 71
###begin article-title 72
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.
###end article-title 72
###begin article-title 73
IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.
###end article-title 73
###begin article-title 74
An important role for type III Interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity.
###end article-title 74
###begin article-title 75
Functional role of type I and type II interferons in antiviral defense.
###end article-title 75
###begin article-title 76
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation.
###end article-title 76
###begin article-title 77
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses.
###end article-title 77
###begin article-title 78
###xml 11 24 <span type="species:ncbi:11569">thogoto virus</span>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Tick-borne thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1.
###end article-title 78
###begin article-title 79
###xml 59 76 <span type="species:ncbi:11320">influenza A virus</span>
Protective role of beta interferon in host defense against influenza A virus.
###end article-title 79
###begin article-title 80
Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7.
###end article-title 80
###begin article-title 81
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.
###end article-title 81
###begin article-title 82
###xml 19 36 <span type="species:ncbi:11320">influenza A virus</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 96 104 <span type="species:ncbi:9031">chickens</span>
Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens.
###end article-title 82
###begin article-title 83
###xml 22 35 <span type="species:ncbi:11569">Thogoto virus</span>
Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist.
###end article-title 83
###begin article-title 84
IFN-lambda: novel antiviral cytokines.
###end article-title 84
###begin article-title 85
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.
###end article-title 85
###begin article-title 86
Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling.
###end article-title 86
###begin article-title 87
Lambda interferon inhibits hepatitis B and C virus replication.
###end article-title 87
###begin article-title 88
IFNs and STATs in innate immunity to microorganisms.
###end article-title 88
###begin article-title 89
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
###end article-title 89
###begin article-title 90
###xml 36 63 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Role for innate IFNs in determining respiratory syncytial virus immunopathology.
###end article-title 90
###begin article-title 91
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus.
###end article-title 91
###begin article-title 92
###xml 83 110 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.
###end article-title 92
###begin article-title 93
###xml 14 19 <span type="species:ncbi:9606">human</span>
A recombinant human interferon-alpha B/D hybrid with a broad host-range.
###end article-title 93
###begin article-title 94
###xml 34 39 <span type="species:ncbi:9606">human</span>
The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures.
###end article-title 94
###begin p 95
The authors have declared that no competing interests exist.
###end p 95
###begin p 96
This work was supported by grant STA 338/7-1 from the Deutsche Forschungsgemeinschaft (DFG) to P.S. and G.K.
###end p 96

